May 9
|
PacBio Announces First Quarter 2024 Financial Results
|
May 7
|
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
|
May 2
|
Investors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to Know
|
Apr 25
|
Here's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 Weeks
|
Apr 23
|
Pacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know
|
Apr 18
|
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 18%
|
Apr 17
|
PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
|
Apr 16
|
The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
|
Apr 16
|
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
|
Apr 3
|
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
|
Mar 27
|
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
|
Mar 22
|
PacBio Grants Equity Incentive Award to New Employee
|
Mar 13
|
11 Oversold NASDAQ Stocks To Buy Right Now
|
Mar 13
|
PacBio's (PACB) New Panel to Aid Its Clinical Research Solution
|
Mar 12
|
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
|
Mar 7
|
Director David Meline Acquires 40,000 Shares of Pacific Biosciences of California Inc (PACB)
|
Jan 16
|
PacBio's (PACB) New PanDNA Kit Ready to Boost DNA Extraction
|
Jan 15
|
PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
|
Jan 9
|
PacBio (PACB) Preliminary Q4 Revenues Boosted by Revio Sales
|
Jan 8
|
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
|